Abstract
The role of surgery in the treatment of benign prostatic hyperplasia has evolved due to the introduction of new forms of energy and devices. This chapter explores the different surgical procedures in the management of benign prostatic hyperplasia. It is organized according to the type of procedure performed based on prostatic volume. For each procedure, a brief technique is described, as well as the efficacy and common complications associated with these urological interventions. This chapter should enable the reader to identify the indications for the surgical management of benign prostatic hyperplasia and compare the most commonly performed surgical procedures in the management of benign prostatic hyperplasia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Park J, Cho S, Cho M, Jeong H, Son H. 5-year long-term efficacy of 120-W GreenLight photoselective vaporization of the prostate for benign prostate hyperplasia. PLoS One. 2017;12(9):e0184442.
Nair S, Pimentel M, Gilling P. A review of laser treatment for symptomatic BPH (Benign Prostatic Hyperplasia). Curr Urol Rep. 2016;17(6):45.
Wasson J, Reda D, Bruskewitz R, Elinson J, Keller A, Henderson W. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. N Engl J Med. 1995;332(2):75–9.
Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008;180(1):246–9.
Roos N, Wennberg J, Malenka D, Fisher E, McPherson K, Andersen T, et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med. 1989;320(17):1120–4.
Graham S, Keane T, Glenn J, Brendler C. Glenn’s urologic surgery. 7th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2010.
Mamoulakis C, Ubbink D, de la Rosette J. Bipolar versus monopolar transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. Eur Urol. 2009;56(5):798–809.
Bachmann A, Tubaro A, Barber N, d’Ancona F, Muir G, Witzsch U, et al. A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol. 2015;193(2):570–8.
Geavlete B, Georgescu D, Multescu R, Stanescu F, Jecu M, Geavlete P. Bipolar plasma vaporization vs monopolar and bipolar TURP–A prospective, randomized, long-term comparison. Urology. 2011;78(4):930–5.
Pavone C, Abbadessa D, Scaduto G, Caruana G, Scalici Gesolfo C, Fontana D, et al. Sexual dysfunctions after transurethral resection of the prostate (TURP): evidence from a retrospective study on 264 patients. Archivio Italiano di Urologia e Andrologia. 2015;87(1):8.
El-Assmy A, ElShal A, Mekkawy R, El-Kappany H, Ibrahiem E. Erectile and ejaculatory functions changes following bipolar versus monopolar transurethral resection of the prostate: a prospective randomized study. Int Urol Nephrol. 2018;50(9):1569–76.
Gravas S, Bachmann A, Reich O, Roehrborn CG, Gilling PJ, Rosette JDL. Critical review of lasers in benign prostatic hyperplasia (BPH). BJU Int. 2011;107(7):1030–43.
Cornu J-N, Ahyai S, Bachmann A, Rosette JDL, Gilling P, Gratzke C, et al. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol. 2015;67(6):1066–96.
Te A, Malloy T, Stein B, Ulchaker J, Nseyo U, Hai M, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol. 2004;172(4):1404–8.
Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol. 2005;19(10):1196–8.
Thomas JA, Tubaro A, Barber N, D’Ancona F, Muir G, Witzsch U, et al. A Multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr outcomes of the GOLIATH study. Eur Urol. 2016;69(1):94–102.
Eken A, Soyupak B, Acil M, Arpaci T, Akbas T. Safety, efficacy and outcomes of the new GreenLight XPS 180W laser system compared to the GreenLight HPS 120W system for the treatment of benign prostatic hyperplasia in a prospective nonrandomized single-centre study. Can Urol Assoc J. 2015;9(1–2):56.
Capitán C, Blázquez C, Martin MD, Hernández V, Peña EDL, Llorente C. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol. 2011;60(4):734–9.
Thangasamy IA, Chalasani V, Bachmann A, Woo HH. Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis from 2002 to 2012. Eur Urol. 2012;62(2):315–23.
Welliver C, Helo S, McVary K. Technique considerations and complication management in transurethral resection of the prostate and photoselective vaporization of the prostate. Transl Androl Urol. 2017;6(4):695–703.
Bachmann A, Schürch L, Ruszat R, Wyler S, Seifert H, Müller A, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-Centre study of perioperative morbidity and early functional outcome. Eur Urol. 2005;48(6):965–72.
Ahyai S, Gilling P, Kaplan S, Kuntz R, Madersbacher S, Montorsi F, et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010;58(3):384–97.
Mcvary KT, Roehrborn CG. Three-year outcomes of the prospective, randomized controlled Rezūm system study: convective radiofrequency thermal therapy for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Urology. 2018;111:1–9.
Mcvary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, et al. Minimally invasive prostate convective water vapor energy ablation: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2016;195(5):1529–38.
Roehrborn C, Gange S, Gittelman M, Goldberg K, Patel K, Shore N, et al. Convective radiofrequency thermal therapy: durable two-year outcomes of a randomized controlled and prospective crossover study to relieve lower urinary tract symptoms due to benign prostatic hyperplasia. J Urol. 2017;197(6):1507–16.
Chung A, Woo H. Update on minimally invasive surgery and benign prostatic hyperplasia. Asian J Urol. 2018;5(1):22–7.
Darson MF, Alexander EE, Schiffman ZJ, Lewitton M, Light RA, Sutton MA, et al. Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rezūm system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Res Rep Urol. 2017;9:159–68.
McVary K, Gange S, Gittelman M, Goldberg K, Patel K, Shore N, et al. Erectile and ejaculatory function preserved with convective water vapor energy treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: randomized controlled study. J Sex Med. 2016;13(6):924–33.
Roehrborn C, Barkin J, Gange S. Five-year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol. 2017;24(3):8802–13.
Roehrborn CG, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, et al. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. study. J Urol. 2013;190(6):2161–7.
Shore N, Freedman S, Gange S, Moseley W, Heron S, Tutrone R, et al. Prospective multicenter study elucidating patient experience after prostatic urethral lift. Can J Urol. 2014;21(1):7094–101.
Pascoe C, Ow D, Perera M, Woo HH, Jack G, Lawrentschuk N. Optimising patient outcomes with photoselective vaporization of the prostate (PVP): a review. Transl Androl Urol. 2017;6(S2):S133–41.
Yun HK, Kwon JB, Cho SR, Kim JS. Early experience with laparoscopic retropubic simple prostatectomy in patients with voluminous benign prostatic hyperplasia (BPH). Korean J Urol. 2010;51(5):323.
Gratzke C, Schlenker B, Seitz M, Karl A, Hermanek P, Lack N, et al. Complications and early postoperative outcome after open prostatectomy in patients with benign prostatic enlargement: results of a prospective multicenter study. J Urol. 2007;177(4):1419–22.
Simforoosh N, Abdi H, Kashi A, Zare S, Tabibi A, Daneshdezfuli A, et al. Open prostatectomy versus transurethral resection of the prostate where do we stand in the new era? A randomized clinical trial. Urol J. 2010;76(4):262–9.
Baumert H. Laparoscopic simple prostatectomy Vs. open simple prostatectomy: the first comparative study. Eur Urol Suppl. 2006;5(2):310.
Autorino R, Zargar H, Mariano MB, Sanchez-Salas R, Sotelo RJ, Chlosta PL, et al. Perioperative outcomes of robotic and laparoscopic simple prostatectomy: a European–American Multi-Institutional Analysis. Eur Urol. 2015;68(1):86–94.
Sivarajan G, Borofsky MS, Shah O, Lingeman JE, Lepor H. The role of minimally invasive surgical techniques in the management of large-gland benign prostatic hypertrophy. Rev Urol. 2015;17(3):140–9.
Cockrell R, Lee DI. Robot-assisted simple prostatectomy: expanding on an established operative approach. Curr Urol Rep. 2017;18(5):37.
Krambeck AE, Handa SE, Lingeman JE. Experience with more than 1,000 holmium laser prostate enucleations for benign prostatic hyperplasia. J Urol. 2010;183(3):1105–9.
Robert G, Cornu J-N, Fourmarier M, Saussine C, Descazeaud A, Azzouzi A-R, et al. Multicentre prospective evaluation of the learning curve of holmium laser enucleation of the prostate (HoLEP). BJU Int. 2015;117(3):495–9.
Elmansy HM, Kotb A, Elhilali MM. Holmium laser enucleation of the prostate: long-term durability of clinical outcomes and complication rates during 10 years of follow up. J Urol. 2011;186(5):1972–6.
Yin L, Teng J, Huang C-J, Zhang X, Xu D. Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. J Endourol. 2013;27(5):604–11.
Elkoushy MA, Elhilali MM. Management of benign prostatic hyperplasia larger than 100 ml: simple open enucleation versus transurethral laser prostatectomy. Curr Urol Rep. 2016;17(6):44.
Gilling PJ, Wilson LC, King CJ, Westenberg AM, Frampton CM, Fraundorfer MR. Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int. 2011;109(3):408–11.
Ekengren J, Zhang W, Hahn R. Effects of bladder capacity and height of fluid bag on intravesical pressure during transurethral resection of the prostate. Eur Urol. 1995;27(1):26–30.
Montorsi F, Naspro R, Salonia A, Suardi N, Briganti A, Zanoni M, et al. Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol. 2004;172(5):1926–9.
Shigemura K, Fujisawa M. Current status of holmium laser enucleation of the prostate. Int J Urol. 2017;25(3):206–11.
Elmansy H, Baazeem A, Kotb A, Badawy H, Riad E, Emran A, et al. Holmium laser enucleation versus photoselective vaporization for prostatic adenoma greater than 60 ml: preliminary results of a prospective, randomized clinical trial. J Urol. 2012;188(1):216–21.
Briganti A, Naspro R, Gallina A, Salonia A, Vavassori I, Hurle R, et al. Impact on sexual function of holmium laser Enucleation versus transurethral resection of the prostate: results of a prospective, 2-center, randomized trial. J Urol. 2006;175(5):1817–21.
Ahyai SA, Lehrich K, Kuntz RM. Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. Eur Urol. 2007;52(5):1456–64.
Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol. 2008;53(1):160–8.
Muntener M, Aellig S, Kuettel R, Gehrlach C, Sulser T, Strebel RT. Sexual function after transurethral resection of the prostate (TURP): results of an independent prospective multicentre assessment of outcome. Eur Urol. 2007;52(2):510–6.
Bruyère F. The relationship between photoselective vaporization of the prostate and sexual function. Curr Urol Rep. 2011;12(4):261–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Abimbola, O., Raynor, M.C. (2020). Indications for Surgical Management of Benign Prostatic Hyperplasia. In: Isaacson, A., Bagla, S., Raynor, M., Yu, H. (eds) Prostatic Artery Embolization. Springer, Cham. https://doi.org/10.1007/978-3-030-23471-3_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-23471-3_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-23470-6
Online ISBN: 978-3-030-23471-3
eBook Packages: MedicineMedicine (R0)